Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells

Li Xingang , Chen Weikai , Gu Junxia , Cui Guohui , Chen Yan

Current Medical Science ›› 2004, Vol. 24 ›› Issue (6) : 572 -574.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (6) : 572 -574. DOI: 10.1007/BF02911358
Article

Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells

Author information +
History +
PDF

Abstract

In order to examine the strong anticancer action and low toxicity of Trichostatin A (TSA), the effect of TSA was examined on the growth inhibition, acetylation of histone H3 and apoptosis in HL-60 cells by employing MTT, immunocytochemical techniques, and Annexin-V-FITC/PI assay. Our results showed that TSA could inhibit proliferation of HL- 60 cells in a time- and dose-dependent manner, and the IC50 at the 36th h was 100 ng/ml. The apoptosis-inducing effect of TSA on HL-60 cells was also time- and dose-dependent. But it didn’t demonstrate apparent apoptosis induction in NPBMNCs within specific dose and time range. Both of the acetylation of histone H3 in HL-60 cells and NPBMNCs increased significantly (P<0.05) after treated with 100 ng/ml TSA for 4 h. However, there was no significant differences between the two groups (P>0.05). It is concluded that TSA can inhibit growth and induce apoptosis of HL-60 cells in a time- and dose-dependent manner, and is able to selectively induce apoptosis in HL-60 cells but does not respond in NPBMNCs under the same conditions. The difference of TSA between HL-60 cells and NPBMNCs cant be explained by the regulation of histone acetylation.

Keywords

Trichostatin A / deacetylase inhibitor / histone acetylation / apoptosis / HL-60 cells

Cite this article

Download citation ▾
Li Xingang, Chen Weikai, Gu Junxia, Cui Guohui, Chen Yan. Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells. Current Medical Science, 2004, 24(6): 572-574 DOI:10.1007/BF02911358

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

RednerR L, WangJ, LiuJ M. Chromatin remodeling and leukemia: New therapeutic paradigms. Blood, 1999, 94: 417-417

[2]

KosugiH, TowatariM, HatanoS, et al. . Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia, 1999, 13: 1316-1316

[3]

ParkW H, JungC W, ParkJ O, et al. . Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis. Int J Oncol, 2003, 22: 1129-1129

[4]

SuzukiT, YokozakiH, KuniyasuH, et al. . Effect of trichostatin A on cell growth and expression of cell cycle-and apoptosis-related molecules in human gastric and oral carcinoma cell lines. Int J Cancer, 2000, 88: 992-992

[5]

AminH M, SaeedS, AlkanS. Histone deacetylase inhibitors induce caspase-dependent apoptosis and down-regulation of daxx in acute promyelocytic leukaemia with t(15; 17). Br J Haematol, 2001, 115: 287-287

[6]

MedinaV, EdmondsB, YoungG P, et al. . Induction of caspase-3 protease activity and apoptosis by Butyrate and Trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a Mitochondrial/cytochrome C-dependent pathway. Cancer Research, 1997, 57: 3697-3697

[7]

VigushinD M, AliS, PaceP E, et al. . Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancerin Vivo. Clin Cancer Res, 2001, 7: 971-971

[8]

NerviC, BorelloU, FaziF, et al. . Inhibition of histone deacetylase activity by Trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity. Cancer Res, 2001, 61: 1247-1247

AI Summary AI Mindmap
PDF

86

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/